NCT06794879 Survey for Parental Perception of Procedural Analgosedation in Pediatric Age.
| NCT ID | NCT06794879 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Analgesia |
| Study Type | OBSERVATIONAL |
| Enrollment | 700 participants |
| Start Date | 2024-12-11 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 700 participants in total. It began in 2024-12-11 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The conduction of this study may provide useful information about how much parents know and understand about procedural sedation, helping to identify any gaps. In addition, expectations and concerns about procedural sedation may be highlighted so that strategies aimed at improving communication by health care personnel can be developed. The results may guide the development of training programs for health care personnel so as to improve the management of procedural sedation and interaction with parents.
Eligibility Criteria
Inclusion Criteria: * Parents of children between the ages of 2 months and 14 years who are afferent to the withdrawal clinic Exclusion Criteria: * None
Contact & Investigator
Laura Andreozzi, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06794879 clinical trial?
This trial is open to participants of all sexes, studying Analgesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06794879 currently recruiting?
Yes, NCT06794879 is actively recruiting participants. Contact the research team at laura.andreozzi@aosp.bo.it for enrollment information.
Where is the NCT06794879 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06794879 clinical trial?
NCT06794879 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Laura Andreozzi, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 700 participants.